TARA

$5.45+0.13 (+2.44%)

Pre-Market$5.56+0.11 (+2.01%)· Last close May 4

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO